1
|
Ouyang R, Feng M, Zhao Y, Liu J, Ma Y, Liu X, Liu B, Miao Y. Cubic Na 0.5Bi 0.5TiO 3 nanoperovskite significantly expands the application of sensitive immunosensor for the detection of carcinoembryonic antigen. Mikrochim Acta 2024; 191:381. [PMID: 38858277 DOI: 10.1007/s00604-024-06451-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2024] [Accepted: 05/18/2024] [Indexed: 06/12/2024]
Abstract
Nanosized sodium bismuth perovskite titanate (NBT) was synthesized and first used as the electrochemical immune sensing platform for the sensitive detection of carcinoembryonic antigen (CEA). Gold nanoparticles (Au NPs) grew on the surface of NBT through forming Au-N bond to obtain Au@NBT, and a label-free electrochemical immunosensor was proposed using Au@NBT as an immunosensing recognizer towards CEA. The well-ordered crystal structure of NBT was not changed at all after the modification of Au NPs outside, but significantly improved the conductivity, catalytic activity, and biocompatibility of the Au@NBT-modified electrode. The unique cubic crystal nanostructure of NBT offered a large active area for both Au NP modification and the subsequent immobilization of biomolecules over the electrode surface, triggering the effective generation of promising properties of the proposed Au@NBT-based electrochemical immunosensor. As expected, favorable detection performances were achieved using this immunosensor towards CEA detection, where a good linear relationship between the current response and CEA concentration was obtained in the concentration range 10 fg mL-1 to 100 ng mL-1 with a low detection limit (LOD) of 13.17 fg mL-1. Also, the significantly enhanced selectivity, and stability guaranteed the promising electrochemical properties of this immunosensor. Furthermore, the analysis of real serum samples verified the high feasibility of this new method in clinical CEA detection. This work opens a new window for the application of nanoperovskite in the early detection of CEA.
Collapse
Affiliation(s)
- Ruizhuo Ouyang
- School of Materials and Chemistry, Institute of Bismuth Science, University of Shanghai for Science and Technology, Shanghai, 200093, China.
| | - Meina Feng
- School of Materials and Chemistry, Institute of Bismuth Science, University of Shanghai for Science and Technology, Shanghai, 200093, China
| | - Yuefeng Zhao
- School of Materials and Chemistry, Institute of Bismuth Science, University of Shanghai for Science and Technology, Shanghai, 200093, China
| | - Jinyao Liu
- School of Materials and Chemistry, Institute of Bismuth Science, University of Shanghai for Science and Technology, Shanghai, 200093, China
| | - Yuanhui Ma
- School of Materials and Chemistry, Institute of Bismuth Science, University of Shanghai for Science and Technology, Shanghai, 200093, China
| | - Xi Liu
- School of Materials and Chemistry, Institute of Bismuth Science, University of Shanghai for Science and Technology, Shanghai, 200093, China
| | - Baolin Liu
- School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, China.
| | - Yuqing Miao
- School of Materials and Chemistry, Institute of Bismuth Science, University of Shanghai for Science and Technology, Shanghai, 200093, China.
| |
Collapse
|
2
|
Siciliano G, Alsadig A, Chiriacò MS, Turco A, Foscarini A, Ferrara F, Gigli G, Primiceri E. Beyond traditional biosensors: Recent advances in gold nanoparticles modified electrodes for biosensing applications. Talanta 2024; 268:125280. [PMID: 37862755 DOI: 10.1016/j.talanta.2023.125280] [Citation(s) in RCA: 11] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2023] [Revised: 10/02/2023] [Accepted: 10/05/2023] [Indexed: 10/22/2023]
Abstract
Gold nanoparticles (AuNPs) have emerged as powerful tools in the construction of highly sensitive electrochemical biosensors. Their unique properties, such as the ability to serve as an effective platform for biomolecule immobilization and to facilitate electron transfer between the electrode surface and the immobilized molecules, make them a promising choice for biosensor applications. Utilizing AuNPs modified electrodes can lead to improved sensitivity and lower limits of detection compared to unmodified electrodes. This review provides a comprehensive overview of the recent advancements and applications of AuNPs-based electrochemical biosensors in the biomedical field. The synthesis methods of AuNPs, their key properties, and various strategies employed for electrode modification are discussed. Furthermore, this review highlights the remarkable applications of these nanostructure-integrated electrodes, including immunosensors, enzyme biosensors, and DNA biosensors.
Collapse
Affiliation(s)
- Giulia Siciliano
- CNR NANOTEC Institute of Nanotechnology, via Monteroni, 73100 Lecce, Italy
| | - Ahmed Alsadig
- CNR NANOTEC Institute of Nanotechnology, via Monteroni, 73100 Lecce, Italy
| | | | - Antonio Turco
- CNR NANOTEC Institute of Nanotechnology, via Monteroni, 73100 Lecce, Italy
| | - Alessia Foscarini
- CNR NANOTEC Institute of Nanotechnology, via Monteroni, 73100 Lecce, Italy
| | - Francesco Ferrara
- CNR NANOTEC Institute of Nanotechnology, via Monteroni, 73100 Lecce, Italy.
| | - Giuseppe Gigli
- CNR NANOTEC Institute of Nanotechnology, via Monteroni, 73100 Lecce, Italy
| | | |
Collapse
|
3
|
Yılmaz M, Bilgi M. A disposable impedimetric immunosensor for the analysis of CA125 in human serum samples. Biomed Microdevices 2024; 26:8. [PMID: 38180587 DOI: 10.1007/s10544-023-00691-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/06/2023] [Indexed: 01/06/2024]
Abstract
Cancer antigen 125 (CA125) is the most common biomarker used to diagnose and monitor ovarian cancer progression for the last four decades, and precise detection of its levels in blood serum is crucial. In this work, label-free impedimetric CA125 immunosensors were fabricated by using screen-printed carbon electrodes modified with poly toluidine blue (PTB) (in deep eutectic solvent)/gold nanoparticles (AuNP) for the sensitive, environmentally friendly, economical, and practical analysis of CA125. The materials of PTBDES and AuNP were characterized by Fourier Transform Infrared (FT-IR), Scanning Electron Microscope (FE-SEM), and X-ray Diffraction (XRD). The analysis of the CA125 was performed by electrochemical impedance spectroscopy and the developed immunosensor. The immunosensor's repeatability, reproducibility, reusability, selectivity, and storage stability were examined. The developed label-free immunosensor allowed the determination of CA125 in fast, good repeatability and a low limit of detection (1.20 pg mL-1) in the linear range of 5-100 pg mL-1. The stable surface of the fabricated immunosensor was successfully regenerated ten times. The application of immunosensors in commercial human blood serum was performed, and good recoveries were achieved. The disposable label-free impedimetric CA125 immunosensor developed for the rapid and practical detection of CA125 is a candidate for use in point-of-care tests in clinical applications of ovarian cancer.
Collapse
Affiliation(s)
- Merve Yılmaz
- Faculty of Science, Chemistry Department, Çankırı Karatekin University, Çankırı, 18100, Türkiye
| | - Melike Bilgi
- Faculty of Science, Chemistry Department, Çankırı Karatekin University, Çankırı, 18100, Türkiye.
| |
Collapse
|
4
|
Cai K, Pi W, Qin J, Peng C, Wang D, Gu Y, Mei Y. Detection of CYFRA 21-1 in human serum by an electrochemical immunosensor based on UiO-66-NH 2@CMWCNTs and CS@AuNPs. Colloids Surf B Biointerfaces 2023; 230:113517. [PMID: 37595377 DOI: 10.1016/j.colsurfb.2023.113517] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2023] [Revised: 07/17/2023] [Accepted: 08/13/2023] [Indexed: 08/20/2023]
Abstract
In this study, an electrochemical immunosensor was constructed to detect the cytokeratin 19 fragment antigen 21-1 (CYFRA 21-1) in human serum. CYFRA 21-1 is the most sensitive tumor marker of non-small cell lung cancer (NSCLC), its content in normal human serum should be less than 3.3 ng/mL. When lung cancer cells dissolve or die, a myriad of CYFRA 21-1 is released into a tumor patient's blood circulation, and its serum content elevates strikingly. Consequently, detecting CYFRA 21-1 by an electrochemical biosensor is expected to provide a new method for the early detection and prevention of lung cancer. In this study, a composite of UiO-66-NH2 and carboxylated multi-walled carbon nanotubes (CMWCNTs) was used as the substrate material of a sensor; the resulting sensor had a large specific surface area and strong electrical conductivity. Moreover, gold nanoparticles (AuNPs) were used to bind to antibodies through an Au-S bonds. Also, a supersensitive detection of CYFRA 21-1 was achieved through the specific bindings of antigens and antibodies. Under optimal detection conditions, the change of current signal intensity of the immunosensor was proportional to the logarithm of CYFRA 21-1 concentration and had a linear relation in the range of 0.005-400 ng/mL, while the detection limit was 1.15 pg/mL (S/N = 3). The proposed immunosensor had high precision, stability, and selectivity. More importantly, the sensor was been successfully applied to detect CYFRA 21-1 in human serum with high recovery, providing a new method for early screening and dynamic monitoring of lung cancer.
Collapse
Affiliation(s)
- Ke Cai
- School of Public Health, Medical College, Wuhan University of Science and Technology, Wuhan, Hubei 430065, PR China; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan, Hubei 430065, PR China
| | - Wei Pi
- School of Public Health, Medical College, Wuhan University of Science and Technology, Wuhan, Hubei 430065, PR China; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan, Hubei 430065, PR China
| | - Jiangyang Qin
- School of Public Health, Medical College, Wuhan University of Science and Technology, Wuhan, Hubei 430065, PR China; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan, Hubei 430065, PR China
| | - Chenxi Peng
- School of Public Health, Medical College, Wuhan University of Science and Technology, Wuhan, Hubei 430065, PR China; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan, Hubei 430065, PR China
| | - Dandan Wang
- School of Public Health, Medical College, Wuhan University of Science and Technology, Wuhan, Hubei 430065, PR China; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan, Hubei 430065, PR China
| | - Yingying Gu
- School of Public Health, Medical College, Wuhan University of Science and Technology, Wuhan, Hubei 430065, PR China; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan, Hubei 430065, PR China; College of Resource and Environmental Engineering, Wuhan University of Science and Technology, Wuhan, Hubei 430065, PR China.
| | - Yong Mei
- School of Public Health, Medical College, Wuhan University of Science and Technology, Wuhan, Hubei 430065, PR China; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan, Hubei 430065, PR China.
| |
Collapse
|
5
|
ÖZÇELİKAY G, ÇETİNKAYA A, KAYA Sİ, ÖZKAN SA. Comparative study of electrochemical-based sensors and immunosensors in terms of advantageous features for detection of cancer biomarkers. Turk J Chem 2023; 47:927-943. [PMID: 38173762 PMCID: PMC10760818 DOI: 10.55730/1300-0527.3587] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2023] [Revised: 10/31/2023] [Accepted: 08/09/2023] [Indexed: 01/05/2024] Open
Abstract
Cancer, becoming increasingly common globally, has a high mortality rate. Despite the much research on diagnosis and treatment methods, the benefits of technological developments, and newly developed sensor devices, cancer is still one of the leading causes of death worldwide. Early detection using powerful and noninvasive tools could be a future focus for prognosis and treatment follow-up. Therefore, electrochemical biosensors can be a strong choice for the detection of cancer biomarkers (such as alpha-fetoprotein, cytochrome c, prostate-specific antigen, myoglobin, carcinoembryonic antigen, alpha-fetoprotein, a cancer antigen, epidermal growth factor receptor, vascular endothelial growth factor, circulating tumor cell, and breast cancer antigen 1/2) due to their advantages such as high sensitivity, excellent selectivity, low cost, short analysis time, and simplicity. Furthermore, electrochemical biosensors are better suited for point-of-care applications due to their mass production and miniaturization ease. This review provides an overview of different electrochemical measurement techniques, bioreceptor surfaces, signal production and amplification, and the integration of electrochemical-modified sensors. Cancer biomarkers based on electrochemical biosensors were given in detail. In addition, studies with MIP-based sensors and immunosensors have been extensively discussed. Integrating electrochemical biosensors with cancer biomarkers was also emphasized as a new research trend. Finally, we provide an overview of current advances in measuring and analyzing cancer biomarkers using electrochemical biosensors and detail current challenges and future perspectives.
Collapse
Affiliation(s)
- Göksu ÖZÇELİKAY
- Department of Analytical Chemistry, Faculty of Pharmacy, Ankara University, Ankara,
Turkiye
| | - Ahmet ÇETİNKAYA
- Department of Analytical Chemistry, Faculty of Pharmacy, Ankara University, Ankara,
Turkiye
- Graduate School of Health Sciences, Ankara University, Ankara,
Turkiye
| | - S. İrem KAYA
- Department of Analytical Chemistry, Gulhane Faculty of Pharmacy, University of Health Sciences, Ankara,
Turkiye
| | - Sibel A. ÖZKAN
- Department of Analytical Chemistry, Faculty of Pharmacy, Ankara University, Ankara,
Turkiye
| |
Collapse
|